PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cepheid, Sunnyvale, California, USA Michael.loeffelholz@cepheid.com.\', \'Center for Emerging Pathogens, Department of Medicine, Rutgers-New Jersey Medical School, Newark New Jersey, USA.\', \'Keck School of Medicine of USC, Department of Pathology, Los Angeles, California, USA.\', \'Children\'s Hospital Los Angeles, Los Angeles, California, USA.\', \'Niguarda Hospital, Ospedale Niguarda Ca\' Granda, Milan, Italy.\', \'The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.\', \'Department of Virology, Manchester University NHS Foundation Trust, Manchester, United Kingdom.\', \'NYC Public Health Laboratory, Department of Health and Mental Hygiene, New York, New York, USA.\', \'Bacteriology-Virology, Henri Mondor Hospital, Creteil, France.\', \'Cepheid, Sunnyvale, California, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • e00926-2010.1128/JCM.00926-20
?:doi
?:hasPublicationType
?:journal
  • Journal of clinical microbiology
is ?:pmid of
?:pmid
?:pmid
  • 32366669
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.256
?:rankingScore_hIndex
  • 226
?:title
  • Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all